| Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/004 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection EU/1/11/672/005 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/006 |
Paliperidone, Paliperidone |
Janssen-Cilag International NV |
— |
| Xeplion 25 mg prolonged-release suspension for injection EU/1/11/672/001 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 50 mg prolonged-release suspension for injection EU/1/11/672/002 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 75 mg prolonged-release suspension for injection EU/1/11/672/003 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xerava 100 mg Powder for concentrate for solution for infusion EU/1/18/1312/003-004 |
ERAVACYCLINE |
Paion Pharma GmbH |
— |
| Xerava 50 mg Powder for concentrate for solution for infusion EU/1/18/1312/001 |
ERAVACYCLINE |
Paion Pharma GmbH |
— |
| Xermelo 250 mg film-coated tablets EU/1/17/1224/001-002 |
Telotristat etiprate |
Serb S.A.S. |
— |
| XGEVA 120 mg solution for injection EU/1/11/703/001-002 |
Denosumab |
Amgen Europe B.V., |
— |
| Xigduo 5 mg/1000 mg film-coated tablets EU/1/13/900/007-012 |
Metformin Hydrochloride, Dapagliflozin propanediol monohydrate |
AstraZeneca AB |
— |
| Xigduo 5 mg/850 mg film-coated tablets EU/1/13/900/001-006 |
Dapagliflozin propanediol monohydrate, Metformin Hydrochloride |
AstraZeneca AB |
— |
| Xiliarx 50 mg tablets EU/1/08/486/1-11 |
Vildagliptin |
Novartis Europharm Limited |
— |
| Xilmac 4 mg/ml Solution for injection PA23314/001/001 |
Lorazepam |
Macure Healthcare Limited |
Not marketed |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/001 |
Ranibizumab |
Stada Arzneimittel AG |
— |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/002 |
Ranibizumab |
Stada Arzneimittel AG |
— |
| Xoanacyl 1 g film-coated tablets EU/1/25/1923/001 |
Ferric citrate coordination complex |
Averoa |
— |
| Xofigo 1100 kBq/mL solution for injection EU/1/13/873/001 |
Radium-223 chloride |
Bayer AG |
— |
| Xofluza 2 mg/mL granules for oral suspension EU/1/20/1500/005 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 20 mg film-coated tablets EU/1/20/1500/001 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 40 mg film-coated tablets EU/1/20/1500/002 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 80 mg film-coated tablets EU/1/20/1500/003 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xolair 150 mg powder and solvent for solution for injection EU/1/05/319/002 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 150 mg solution for injection in pre-filled syringe EU/1/05/319/8-10 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 300 mg solution for injection in pre-filled pen EU/1/05/319/015-017 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 300 mg solution for injection in pre-filled syringe EU/1/05/319/012-014 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 75 mg powder and solvent for solution for injection EU/1/05/319/001 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 75 mg solution for injection in pre-filled syringe EU/1/05/319/5-7 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xonvea 10 mg/10 mg gastro-resistant tablets PA22998/006/001 |
Pyridoxine hydrochloride, DOXYLAMINE SUCCINATE |
Exeltis Healthcare S.L. |
Not marketed |
| Xonvea MR 20 mg/20 mg modified-release tablets PA22998/003/001 |
Doxylamine hydrogen succinate, Pyridoxine hydrochloride |
Exeltis Healthcare S.L. |
Not marketed |
| Xospata 40 mg film-coated tablets EU/1/19/1399/001 |
Gilteritinib fumarate |
Astellas Pharma Europe B.V. |
— |
| Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/13/863/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Xromi 100 mg/ml oral solution EU/1/19/1366/001 |
Hydroxycarbamide |
Lipomed GmbH |
— |
| Xtandi 40 mg film-coated tablets EU/1/13/846/002 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |
| Xtandi 40 mg soft capsules EU/1/13/846/001 |
Enzalutamide |
Astellas Pharma Europe BV |
— |
| Xtandi 80 mg film-coated tablets EU/1/13/846/003 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |
| Xtex 250 mg /5 ml oral solution PA0074/071/001 |
Carbocisteine |
Rowa Pharmaceuticals Limited, |
Marketed |
| Xultophy 100 units/mL + 3.6 mg/mL solution for injection. EU/1/14/947/001-004 |
Insulin degludec, Liraglutide |
Novo Nordisk A/S |
— |
| Xydalba EU/1/14/986/001 |
Dalbavancin hcl |
AbbVie Deutschland GmbH & Co. KG |
— |
| Xylocaine 10 mg/delivered dose Mucosal Spray PA1691/028/001 |
Lidocaine |
Aspen Pharma Trading Limited |
Marketed |
| Xylocaine 2% w/v with Adrenaline (Epinephrine) 1:80,000 DENTAL Solution for Injection PA1045/003/001 |
Lidocaine hydrochloride, Adrenaline |
DENTSPLY DeTrey GmbH |
Marketed |
| Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection PA1691/027/001 |
Lidocaine hydrochloride, Adrenaline |
Aspen Pharma Trading Limited |
Marketed |
| Xylocaine 20mg/g Gel PA1691/037/001 |
Lidocaine Hydrochloride Monohydrate |
Aspen Pharma Trading Limited |
Not marketed |
| Xylonor, 50 mg/g + 1.5 mg/g, gingival gel PA0196/014/002 |
Lidocaine, Cetrimide |
Septodont |
Marketed |
| Xymel Comp 37.5mg/325mg Film-Coated Tablets PA0126/244/001 |
Tramadol hydrochloride, Paracetamol |
Clonmel Healthcare Ltd |
Marketed |
| Xyrem 500 mg/mL oral solution EU/1/05/312/001 |
Sodium Oxybate |
UCB Pharma S.A. |
— |
| Xyzal 0.5 mg/ml oral solution PA0891/003/003 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Xyzal 0.5 mg/ml oral solution PPA1463/170/001 |
Levocetirizine dihydrochloride |
IMED Healthcare Ltd., |
— |
| Xyzal 5 mg film-coated tablets PA0891/003/001 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Xyzal 5 mg/ml oral drops, solution PA0891/003/002 |
Levocetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Not marketed |